Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation
Author:
Publisher
Springer Singapore
Link
http://link.springer.com/content/pdf/10.1007/978-981-13-8871-2_12
Reference174 articles.
1. Ai J, Nie J, He J, Guo Q, Li M, Lei Y et al (2015) GQ5 hinders renal fibrosis in obstructive nephropathy by selectively inhibiting TGF-beta-induced Smad3 phosphorylation. J Am Soc Nephrol 26:1827–1838
2. Allinovi M, De Chiara L, Angelotti ML, Becherucci F, Romagnani P (2018) Anti-fibrotic treatments: a review of clinical evidence. Matrix Biol 69:333–354
3. Asada N, Takase M, Nakamura J, Oguchi A, Asada M, Suzuki N et al (2011) Dysfunction of fibroblasts of extrarenal origin underlies renal fibrosis and renal anemia in mice. J Clin Invest 121:3981–3990
4. Avery D, Govindaraju P, Jacob M, Todd L, Monslow J, Puré E (2018) Extracellular matrix directs phenotypic heterogeneity of activated fibroblasts. Matrix Biol 67:90–106
5. Barnes JL, Gorin Y (2011) Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int 79:944–956
Cited by 130 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Renal Mast Cell-Specific Proteases in the Pathogenesis of Tubulointerstitial Fibrosis;Journal of Histochemistry & Cytochemistry;2024-09-12
2. Endogenous bufadienolides, mineralocorticoid receptor antagonists and fibrosis in chronic kidney disease;Frontiers in Pharmacology;2024-09-04
3. Trimetazidine Alleviates Bleomycin-Induced Pulmonary Fibrosis by Targeting the Long Noncoding RNA CBR3-AS1-Mediated miRNA-29 and Resistin-Like Molecule alpha 1: Deciphering a Novel Trifecta Role of LncRNA CBR3-AS1/miRNA-29/FIZZ1 Axis in Lung Fibrosis;Drug Design, Development and Therapy;2024-09
4. BRD4: an effective target for organ fibrosis;Biomarker Research;2024-08-30
5. miR‐542‐5p targets GREM1 to affect the progression of renal fibrosis;Journal of Biochemical and Molecular Toxicology;2024-08-24
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3